Seven associations from the pharmaceutical and cosmetic sectors have called for a review of the application of the EU Wastewater Directive and its new Extended Producer Responsibility (RAP) regime. Working with consulting firm PwC, these industry groups are examining the technical, economic, and legal challenges posed by the new regulatory framework. Under the new regime, producers will be obligated to finance at least 80% of the costs associated with quaternary (advanced) wastewater treatment. This represents a significant shift in producer financial responsibility for wastewater management and treatment beyond conventional secondary treatment levels. The associations are seeking clarification and potential adjustments to the implementation of these requirements.